What Researchers Did
Researchers reviewed existing literature on musculoskeletal oxygenation alterations in fibromyalgia and myalgic encephalomyelitis patients and presented three case studies.
What They Found
The review highlighted that patients with fibromyalgia and myalgic encephalomyelitis often experience musculoskeletal oxygenation alterations and respond to treatments like hyperbaric oxygen therapy and coenzyme Q10. Additionally, three patients with severe symptom exacerbations showed successful responses to treatment with pure oxygen for a limited time.
What This Means for Canadian Patients
Canadian patients with fibromyalgia or myalgic encephalomyelitis experiencing acute symptom exacerbations might consider discussing oxygen therapy with their healthcare providers, especially if other treatments are ineffective. This approach could offer a temporary relief option for severe symptoms, though further research is needed to establish long-term benefits.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The study's primary limitations include the small number of patients treated and the absence of statistical methodology, preventing definitive conclusions.